Treffer: Integrative bioengineering strategies for endometrial regeneration: From biomaterials and stem cells to organoids and organ-on-a-chip technologies.

Title:
Integrative bioengineering strategies for endometrial regeneration: From biomaterials and stem cells to organoids and organ-on-a-chip technologies.
Authors:
Kim SR; Department of Health Sciences and Technology, GAIHST, Gachon University, Incheon 21999, Republic of Korea.; Department of Molecular Medicine, School of Medicine, Gachon University, Incheon 406-840, Republic of Korea., Lee HY; Division of Science Education, Kangwon National University, Chuncheon 24341, Republic of Korea.
Source:
Theranostics [Theranostics] 2026 Jan 01; Vol. 16 (2), pp. 736-775. Date of Electronic Publication: 2026 Jan 01 (Print Publication: 2026).
Publication Type:
Journal Article; Review
Language:
English
Journal Info:
Publisher: Ivyspring International Publisher Country of Publication: Australia NLM ID: 101552395 Publication Model: eCollection Cited Medium: Internet ISSN: 1838-7640 (Electronic) Linking ISSN: 18387640 NLM ISO Abbreviation: Theranostics Subsets: MEDLINE
Imprint Name(s):
Original Publication: Wyoming, N.S.W. : Ivyspring International Publisher, 2011-
References:
Adv Mater. 2024 Jun;36(23):e2310301. (PMID: 38298130)
Heliyon. 2023 May 13;9(5):e16228. (PMID: 37234631)
Int J Surg. 2024 Jun 01;110(6):3237-3248. (PMID: 38935827)
Stem Cell Res Ther. 2025 Aug 27;16(1):464. (PMID: 40866943)
Bioimpacts. 2023;13(3):229-240. (PMID: 37431484)
Front Immunol. 2023 Oct 23;14:1269960. (PMID: 37936689)
Nat Cell Biol. 2019 Aug;21(8):1041-1051. (PMID: 31371824)
Front Bioeng Biotechnol. 2025 Feb 26;13:1551791. (PMID: 40078795)
Colloids Surf B Biointerfaces. 2023 Feb;222:113088. (PMID: 36577342)
Bioact Mater. 2024 Apr 23;37:348-377. (PMID: 38694766)
ACS Nano. 2025 Feb 18;19(6):6499-6510. (PMID: 39915116)
Adv Sci (Weinh). 2025 Jul;12(25):e2501053. (PMID: 40178018)
ACS Omega. 2024 Aug 01;9(32):34314-34328. (PMID: 39157094)
Gels. 2023 Jan 23;9(2):. (PMID: 36826270)
Polymers (Basel). 2022 Mar 14;14(6):. (PMID: 35335484)
Asian J Surg. 2024 Aug 30;:. (PMID: 39217010)
Diagnostics (Basel). 2025 Apr 09;15(8):. (PMID: 40310333)
Reprod Sci. 2021 Jun;28(6):1644-1658. (PMID: 33511539)
Adv Healthc Mater. 2022 Nov;11(21):e2201680. (PMID: 36049781)
Endocrinology. 2021 Jun 1;162(6):. (PMID: 33693651)
Int J Mol Sci. 2020 Mar 13;21(6):. (PMID: 32183093)
Arch Razi Inst. 2023 Dec 30;78(6):1762-1770. (PMID: 38828173)
iScience. 2022 Nov 24;25(12):105657. (PMID: 36536678)
Reprod Sci. 2021 Jun;28(6):1596-1611. (PMID: 33826100)
Cells. 2021 Nov 23;10(12):. (PMID: 34943786)
Acta Biomater. 2021 Nov;135:113-125. (PMID: 34428563)
Int J Mol Sci. 2023 Apr 20;24(8):. (PMID: 37108764)
Reprod Biomed Online. 2024 Oct;49(4):104273. (PMID: 39033691)
ACS Appl Mater Interfaces. 2024 Feb 14;16(6):6772-6788. (PMID: 38295266)
Acta Biomater. 2025 Mar 15;195:201-215. (PMID: 39894327)
Reprod Sci. 2025 Mar;32(3):895-906. (PMID: 39909974)
Biotechnol Lett. 2015 Nov;37(11):2139-45. (PMID: 26160110)
J Mater Chem B. 2025 Jul 16;13(28):8496-8509. (PMID: 40548465)
Mar Drugs. 2023 Mar 18;21(3):. (PMID: 36976238)
Bioact Mater. 2024 Jun 14;40:280-305. (PMID: 38973992)
World J Stem Cells. 2025 Jan 26;17(1):97905. (PMID: 39866901)
Biol Reprod. 2025 Jul 13;113(1):61-82. (PMID: 40188483)
Acta Biomater. 2024 Mar 15;177:77-90. (PMID: 38331133)
Cell Tissue Res. 2023 Nov;394(2):379-392. (PMID: 37759141)
Mol Hum Reprod. 2023 May 31;29(6):. (PMID: 37171897)
J Nanobiotechnology. 2024 Jul 31;22(1):455. (PMID: 39085921)
ACS Biomater Sci Eng. 2021 Jan 11;7(1):222-231. (PMID: 33347290)
Biol Reprod. 2020 Oct 29;103(5):918-926. (PMID: 32697306)
Gels. 2024 Jul 26;10(8):. (PMID: 39195026)
Acta Biomater. 2020 Sep 1;113:252-266. (PMID: 32574858)
Biomater Sci. 2020 Feb 7;8(3):988-996. (PMID: 31868868)
Asian J Pharm Sci. 2021 May;16(3):280-306. (PMID: 34276819)
J Plast Surg Hand Surg. 2013 Dec;47(6):498-502. (PMID: 23596989)
Polymers (Basel). 2024 Oct 10;16(20):. (PMID: 39458681)
Biofabrication. 2021 Aug 16;13(4):. (PMID: 34284368)
Biomater Res. 2023 Oct 7;27(1):100. (PMID: 37805518)
Int J Bioprint. 2022 Jul 26;8(3):597. (PMID: 36105140)
Biomater Res. 2023 Dec 24;27(1):137. (PMID: 38142273)
J Hazard Mater. 2024 Aug 15;475:134900. (PMID: 38878440)
Exploration (Beijing). 2024 Apr 17;4(5):20230141. (PMID: 39439492)
Bioact Mater. 2023 Sep 09;31:475-496. (PMID: 37719085)
Int J Biol Macromol. 2024 Aug;275(Pt 1):133458. (PMID: 38945326)
Eur J Pharm Sci. 2020 May 30;148:105316. (PMID: 32201342)
Int J Biol Macromol. 2022 Oct 31;219:96-108. (PMID: 35902020)
Stem Cell Res Ther. 2022 Feb 8;13(1):66. (PMID: 35135594)
Aging (Albany NY). 2024 Apr 1;16(7):6273-6289. (PMID: 38568100)
F S Sci. 2024 Feb;5(1):58-68. (PMID: 38145868)
Adv Drug Deliv Rev. 2024 Aug;211:115347. (PMID: 38844005)
Mater Today Bio. 2025 Feb 04;31:101551. (PMID: 40026632)
MedComm (2020). 2023 Dec 01;4(6):e425. (PMID: 38045828)
Biofabrication. 2015 May 28;7(2):025010. (PMID: 26019144)
Reprod Med Biol. 2021 Jul 31;20(4):371-401. (PMID: 34646066)
Am J Transl Res. 2023 May 15;15(5):3203-3216. (PMID: 37303669)
FASEB J. 2022 Oct;36(10):e22551. (PMID: 36106554)
Int J Stem Cells. 2020 Nov 30;13(3):414-423. (PMID: 33250449)
Sci Rep. 2025 Feb 24;15(1):6636. (PMID: 39994247)
Med. 2023 Aug 11;4(8):554-579.e9. (PMID: 37572651)
Sci Rep. 2024 Oct 6;14(1):23250. (PMID: 39370419)
Int J Stem Cells. 2025 May 30;18(2):135-145. (PMID: 39995273)
Pharmaceuticals (Basel). 2023 Mar 17;16(3):. (PMID: 36986553)
Mater Today Bio. 2023 Nov 18;23:100855. (PMID: 38075258)
Molecules. 2023 Apr 03;28(7):. (PMID: 37049957)
Clin Exp Reprod Med. 2022 Dec;49(4):259-269. (PMID: 36482500)
Bioact Mater. 2024 Jan 17;34:494-519. (PMID: 38298755)
Nat Cell Biol. 2017 May;19(5):568-577. (PMID: 28394884)
Int J Biol Macromol. 2024 May;268(Pt 1):131723. (PMID: 38649072)
Biomater Res. 2021 Nov 24;25(1):40. (PMID: 34819167)
Hum Reprod. 2024 Nov 1;39(11):2537-2550. (PMID: 39277544)
Bioact Mater. 2023 Oct 04;32:98-123. (PMID: 37927899)
Biomacromolecules. 2025 Mar 10;26(3):1771-1787. (PMID: 39988967)
Biofabrication. 2025 Feb 06;17(2):. (PMID: 39854843)
Bioact Mater. 2023 Nov 26;33:355-376. (PMID: 38282639)
Acta Biomater. 2023 Sep 1;167:205-218. (PMID: 37331615)
Prog Polym Sci. 2016 Feb 1;53:86-168. (PMID: 27022202)
Tissue Eng Part A. 2025 Jan;31(1-2):29-44. (PMID: 38526390)
Acta Biomater. 2020 Oct 15;116:268-284. (PMID: 32911103)
Proc Natl Acad Sci U S A. 2019 Nov 12;116(46):23132-23142. (PMID: 31666317)
Gynecol Endocrinol. 2024 Dec;40(1):2442728. (PMID: 39708335)
J Genet Eng Biotechnol. 2021 Feb 1;19(1):23. (PMID: 33523322)
Molecules. 2024 May 26;29(11):. (PMID: 38893391)
Hum Reprod. 2021 Sep 18;36(10):2720-2731. (PMID: 34363466)
Adv Healthc Mater. 2024 May;13(13):e2303674. (PMID: 38315148)
Hum Reprod Update. 2022 Nov 2;28(6):798-837. (PMID: 35652272)
J Minim Invasive Gynecol. 2022 Feb;29(2):284-290. (PMID: 34433103)
Regen Biomater. 2025 Mar 17;12:rbaf013. (PMID: 40196171)
Reprod Sci. 2024 Jun;31(6):1662-1673. (PMID: 38294669)
AJOG Glob Rep. 2023 Jan 05;3(1):100154. (PMID: 36691400)
J Pers Med. 2021 Jun 03;11(6):. (PMID: 34205034)
Front Behav Neurosci. 2020 Dec 16;14:597690. (PMID: 33424559)
J Biol Eng. 2023 Mar 20;17(1):21. (PMID: 36941601)
Tissue Eng Regen Med. 2022 Dec;19(6):1337-1347. (PMID: 36161585)
J Hum Reprod Sci. 2019 Oct-Dec;12(4):287-293. (PMID: 32038077)
J Funct Biomater. 2025 Feb 24;16(3):. (PMID: 40137359)
Front Bioeng Biotechnol. 2024 Feb 14;12:1358246. (PMID: 38419725)
Front Bioeng Biotechnol. 2024 Apr 04;12:1327207. (PMID: 38638324)
Drug Deliv. 2020 Dec;27(1):1165-1175. (PMID: 32755258)
Int J Biol Macromol. 2023 May 1;236:123943. (PMID: 36889621)
Gels. 2024 Oct 23;10(11):. (PMID: 39590034)
Adv Mater. 2024 Sep;36(39):e2407750. (PMID: 39115352)
Mil Med Res. 2023 Mar 28;10(1):16. (PMID: 36978167)
Biomedicines. 2020 Nov 21;8(11):. (PMID: 33233463)
Acta Biomater. 2023 Feb;157:187-199. (PMID: 36521675)
J Oral Biol Craniofac Res. 2020 Jan-Mar;10(1):381-388. (PMID: 31754598)
Biofabrication. 2025 Aug 07;17(4):. (PMID: 40513614)
ACS Appl Mater Interfaces. 2024 Jul 31;16(30):39140-39152. (PMID: 39022819)
Biomacromolecules. 2022 May 9;23(5):1841-1863. (PMID: 35438479)
Genes Dis. 2022 Aug 31;10(3):931-947. (PMID: 37396532)
Adv Sci (Weinh). 2024 Nov;11(44):e2409778. (PMID: 39373358)
Adv Sci (Weinh). 2025 May;12(20):e2504647. (PMID: 40289897)
Int J Biol Macromol. 2024 Jun;270(Pt 1):132363. (PMID: 38754675)
Bioact Mater. 2023 Jun 27;28:511-536. (PMID: 37435177)
Cell Death Dis. 2022 Jul 4;13(7):580. (PMID: 35787632)
Stem Cell Res Ther. 2017 Apr 18;8(1):84. (PMID: 28420433)
Adv Healthc Mater. 2024 Apr;13(11):e2303838. (PMID: 37983675)
Proc Natl Acad Sci U S A. 2022 Nov;119(44):e2208040119. (PMID: 36279452)
Polymers (Basel). 2022 Aug 19;14(16):. (PMID: 36015652)
Stem Cell Res Ther. 2022 Jan 12;13(1):17. (PMID: 35022063)
Commun Biol. 2019 May 22;2:196. (PMID: 31123719)
Mol Cells. 2024 Dec;47(12):100151. (PMID: 39547584)
Front Bioeng Biotechnol. 2023 Aug 31;11:1264006. (PMID: 37720318)
Physiol Rev. 2020 Jul 1;100(3):1149-1179. (PMID: 32031903)
Front Bioeng Biotechnol. 2022 Apr 13;10:868734. (PMID: 35497344)
Sci Rep. 2024 Apr 19;14(1):9012. (PMID: 38641671)
Biochem Cell Biol. 2022 Aug 1;100(4):357-369. (PMID: 36043683)
Signal Transduct Target Ther. 2022 Mar 21;7(1):92. (PMID: 35314676)
J Pathol Inform. 2024 Feb 01;15:100364. (PMID: 38445292)
Drug Deliv Transl Res. 2025 Dec;15(12):4638-4653. (PMID: 40195258)
Biofabrication. 2020 Oct 16;13(1):. (PMID: 32998123)
Regen Biomater. 2023 Apr 03;10:rbad033. (PMID: 37122820)
Contributed Indexing:
Keywords: 3D bioprinting; biomaterials; endometrial regeneration; infertility; organ-on-a-chip; organoids; stem cells; tissue engineering
Substance Nomenclature:
0 (Biocompatible Materials)
Entry Date(s):
Date Created: 20251205 Date Completed: 20251205 Latest Revision: 20260102
Update Code:
20260102
PubMed Central ID:
PMC12674934
DOI:
10.7150/thno.123298
PMID:
41346706
Database:
MEDLINE

Weitere Informationen

Endometrial regeneration remains a significant clinical challenge for women with intrauterine adhesions (IUAs), thin endometrium, or uterine factor infertility, conditions that severely impair fertility and reproductive outcomes. Traditional hormonal and surgical interventions often fail to restore the structural and functional integrity of damaged endometrial tissue. This review comprehensively examines integrative bioengineering strategies for endometrial regeneration, focusing on the synergistic applications of biomaterials, stem cells, organoids, and organ-on-a-chip technologies. Natural polymers such as collagen, gelatin, alginate, hyaluronic acid, and synthetic polymers including PCL, PLA, PGA, and PLGA have been comprehensively evaluated for their ability to mimic extracellular matrix, support cell proliferation, angiogenesis, and modulate immune responses. The incorporation of mesenchymal stem cells, extracellular vesicles, and growth factors into bioengineered scaffolds, such as hydrogels and nanofiber membranes, enhances regenerative efficacy. Furthermore, emerging platforms, such as endometrial organoids, 3D bioprinting, and organ-on-a-chip systems, offer physiologically relevant models for precision regenerative medicine. Innovations such as AI-assisted monitoring, 4D printing, and advanced drug delivery systems represent transformative approaches to overcome current therapeutic limitations. This review highlights the convergence of materials science, stem cell biology, and microengineering as a foundation for next-generation, personalized therapies aimed at restoring endometrial function and fertility. In addition, the review highlights biomaterial-based strategies as the foundation of endometrial regeneration, by detailing how natural polymers (e.g., collagen, gelatin, alginate, hyaluronic acid) and synthetic polymers (e.g., PCL, PLA, PLGA) support tissue repair structurally and by mediating biological functions. The integration of advanced technologies, such as 4D printing, AI-assisted monitoring, and stem cell-derived extracellular vesicle delivery has emerged as a transformative direction for overcoming current clinical challenges. Collectively, these approaches offer a next-generation therapeutic paradigm for restoring endometrial function and fertility.
(© The author(s).)

Competing interests: The authors have declared that no competing interest exists.